Home Brand News Shilpa Medicare Ltd has received U.S. Food and Drug Administration approval

Shilpa Medicare Ltd has received U.S. Food and Drug Administration approval

64
0

Jan 17, 2019 :Shilpa Medicare Ltd has received U.S. Food and Drug Administration approval for its ANDA, Imatinib Mesylate Tablets, 100 mg and 400 mg.
Imatinib Mesylate Tablets is a generic equivalent of reference listed drug (RLD), Gleevec Tablets, 100 mg and 400 mg used in the treatment of leukemia as recommended in the label approved by FDA

LEAVE A REPLY

Please enter your comment!
Please enter your name here